Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil V Badve

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Kidney International|December 21, 2012
Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal diseaseWen Tang, Stephen P McDonald, Carmel M Hawley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2012
Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysisRathika Krishnasamy, Sunil V Badve, Carmel M Hawley, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 15, 2016
Center-Specific Factors Associated with Peritonitis Risk-A Multi-Center Registry AnalysisAnnie-Claire Nadeau-Fredette, David W Johnson, Carmel M Hawley, et al.
The Lancet. Rheumatology|January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS ProgramJingWei Li, Sunil V Badve, Zien Zhou, et al.
Kidney International Reports|February 12, 2024
The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice DatasetMin Jun, James Wick, Brendon L Neuen, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trialMin Jun, Katie Harris, Hiddo J L Heerspink, et al.
BMC Nephrology|December 5, 2012
End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry casesWen Tang, Janaki Mohandas, Stephen P McDonald, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2017
Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal DialysisHtay Htay, Yeoungjee Cho, Elaine M Pascoe, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2018
Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National RegistryHtay Htay, Yeoungjee Cho, Elaine M Pascoe, et al.
Journal of Cardiac Failure|March 1, 2026
SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m<sup>2</sup>Safia Chatur, Robert A Fletcher, Emily Yeung, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Kidney International|December 21, 2012
Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal diseaseWen Tang, Stephen P McDonald, Carmel M Hawley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2012
Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysisRathika Krishnasamy, Sunil V Badve, Carmel M Hawley, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 15, 2016
Center-Specific Factors Associated with Peritonitis Risk-A Multi-Center Registry AnalysisAnnie-Claire Nadeau-Fredette, David W Johnson, Carmel M Hawley, et al.
The Lancet. Rheumatology|January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS ProgramJingWei Li, Sunil V Badve, Zien Zhou, et al.
Kidney International Reports|February 12, 2024
The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice DatasetMin Jun, James Wick, Brendon L Neuen, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trialMin Jun, Katie Harris, Hiddo J L Heerspink, et al.
BMC Nephrology|December 5, 2012
End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry casesWen Tang, Janaki Mohandas, Stephen P McDonald, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2017
Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal DialysisHtay Htay, Yeoungjee Cho, Elaine M Pascoe, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2018
Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National RegistryHtay Htay, Yeoungjee Cho, Elaine M Pascoe, et al.
Journal of Cardiac Failure|March 1, 2026
SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m<sup>2</sup>Safia Chatur, Robert A Fletcher, Emily Yeung, et al.
Pageof 15